Granulomatous dermatitis in the context of chronic myelomonocytic leukemia: More than just reactive infiltrates. An illustrative case report with literature review.

chronic myelomonocytic leukemia clonality cytoreductive treatment granulomatous dermatitis myelodysplastic/myeloproliferative neoplasms skin

Journal

Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124

Informations de publication

Date de publication:
06 May 2024
Historique:
revised: 05 09 2023
received: 24 06 2023
accepted: 24 04 2024
medline: 7 5 2024
pubmed: 7 5 2024
entrez: 7 5 2024
Statut: aheadofprint

Résumé

Traditionally, skin involvement in chronic myelomonocytic leukemia (CMML) has been considered to be either specific (leukemia cutis) or non-specific, with granulomatous dermatitis included in the latter group. More recently, the true nature of the myeloid cells present in the cutaneous infiltrates of this theoretically reactive dermatitis is being clarified with the use of new molecular techniques such as next-generation sequencing. The same mutations in bone marrow (BM) myeloid neoplastic cells and in the cells of cutaneous infiltrates have been found. We present the case of a 77-year-old man who presented with spread and treatment-resistant skin granulomatous lesions previous to the diagnosis of CMML. The same clonal mutations in SRSF2, IDH1, and RUNX1 were found in both skin and BM with resolution of the lesions after the initiation of azacytidine. In conclusion, we report an exceptional case in which specific granulomatous cutaneous lesions have preceded and allowed the earlier diagnosis of an underlying CMML and a review of all previous similar cases in the literature, including molecular alterations.

Identifiants

pubmed: 38711181
doi: 10.1111/cup.14638
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703‐1719. doi:10.1038/s41375‐022‐01613‐1
Federmann B, Bonzheim I, Yazdi AS, Schmidt J, Fend F, Metzler G. Generalized palisaded neutrophilic and granulomatous dermatitis‐a cutaneous manifestation of chronic myelomonocytic leukemia? A clinical, histopathological, and molecular study of 3 cases. Hum Pathol. 2017;64:198‐206. doi:10.1016/j.humpath.2017.04.010
Prieto‐Torres L, Santonja C, Chamizo C, et al. Granulomatous dermatitis heralding myelodisplastic/myeloproliferative neoplasms. Neoplastic or reactive cells? A study of 2 cases. Am J Dermatopathol. 2022;44(6):456‐460. doi:10.1097/DAD.0000000000002149
Enescu CD, Patel A, Friedman BJ. Unique recognizable histopathologic variant of palisaded neutrophilic and granulomatous dermatitis that is associated with SRSF2‐mutated chronic myelomonocytic leukemia: case report and review of the literature. Am J Dermatopathol. 2022;44(3):e33‐e36. doi:10.1097/DAD.0000000000002085
Arber DA, Orazi A, Hasserjian RP, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200‐1228. doi:10.1182/blood.2022015850
Elena C, Gallì A, Such E, et al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016;128(10):1408‐1417. doi:10.1182/blood‐2016‐05‐714030
Ferea CR, Mihai SN, Balan G, Badescu MC, Tutunaru D, Tatu AL. Sweet syndrome associated with myelodysplastic syndrome—a review of a multidisciplinary approach. Life. 2023;13(3):809. doi:10.3390/life13030809
Passet M, Lepelletier C, Vignon‐Pennamen MD, et al. Next‐generation sequencing in myeloid neoplasm‐associated Sweet's syndrome demonstrates clonal relation between malignant cells and skin‐infiltrating neutrophils. J Invest Dermatol. 2020;140(9):1873‐1876.e5. doi:10.1016/j.jid.2019.12.040
Osio A, Battistella M, Feugeas JP, et al. Myelodysplasia cutis versus leukemia cutis. J Invest Dermatol. 2015;135(9):2321‐2324. doi:10.1038/jid.2015.146
Delaleu J, Kim R, Zhao LP, et al. Clinical, pathological, and molecular features of myelodysplasia cutis. Blood. 2022;139(8):1251‐1253. doi:10.1182/blood.2021013967
Vitte F, Fabiani B, Bénet C, et al. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases. Am J Surg Pathol. 2012;36(9):1302‐1316. doi:10.1097/PAS.0b013e31825dd4de
Machan S, Alonso‐Dominguez JM, Sánchez García FJ, et al. Plasmacytoid dendritic cell dermatosis associated to myeloproliferative/myelodysplastic neoplasms. Am J Surg Pathol. 2022;46(12):1623‐1632. doi:10.1097/PAS.0000000000001960
Kyriakou A, Patsatsi A, Papadopoulos V, Kioumi A, Efstratiou I, Lazaridou E. A case of palisaded neutrophilic granulomatous dermatitis with subsequent development of chronic myelomonocytic leukemia. Clin Case Rep. 2019;7(4):695‐698. doi:10.1002/ccr3.2072
Yoneta K, Fujimoto N, Teramura K, Takayama S, Tanaka T. Disseminated granulomatous skin lesions associated with myelodysplastic syndrome treated successfully with tranilast: a case report and review of the literature. Eur J Dermatol. 2016;26(4):398‐400. doi:10.1684/ejd.2016.2812

Auteurs

Mar García-García (M)

Pathology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Surgery Department, University of Zaragoza (UNIZAR), Zaragoza, Spain.

Julia Jiménez Elbaile (JJ)

Surgery Department, University of Zaragoza (UNIZAR), Zaragoza, Spain.

Gemma Azaceta (G)

Hematology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

Marta Lorda (M)

Dermatology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

Lucía Prieto-Torres (L)

Dermatology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

Classifications MeSH